NSIM
MBOT icon

North Star Investment Management’s Microbot Medical MBOT Stock Holding History

North Star Investment Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-650
Closed -$3K – 1159
2022
Q2 		$3K Hold
650
– – ﹤0.01% 1014
2022
Q1 		$4K Hold
650
– – ﹤0.01% 1008
2021
Q4 		$5K Buy
+650
New +$4.19K ﹤0.01% 998

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

North Star Investment Management's MBOT Position: Q3 2022 in Review

North Star Investment Management sold out of Microbot Medical (MBOT) in Q3 2022, closing a stake of 650 shares — an estimated $3K sold.

North Star Investment Management first reported a position in MBOT in Q4 2021 and held it in 3 quarters. The position peaked at $5K in Q4 2021. 23 funds tracked by Wall St. Rank hold MBOT as of Q3 2022.

  • North Star Investment Management reported no remaining Microbot Medical position as of Q3 2022 after selling out during the quarter.
  • North Star Investment Management sold 650 Microbot Medical shares in Q3 2022, an estimated $3K.
  • North Star Investment Management first reported a position in Microbot Medical in Q4 2021 and held it in 3 quarters.
  • North Star Investment Management's Microbot Medical position peaked at $5K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2022.

Based on North Star Investment Management's 13F filing for Q3 2022, filed 2 Nov 2022.